Skip to main navigation
Skip to search
Skip to main content
Amsterdam UMC Home
Help & FAQ
Link opens in a new tab
Search content at Amsterdam UMC
Home
Researchers
Departments & Research Institutes
Projects & Funding
Publications
Datasets
Prizes
Activities
Courses
Cohorts
Press/Media
Impact
Treatment of breast cancer during pregnancy: an observational study
Sibylle Loibl
, Sileny N. Han
, Gunter von Minckwitz
, Marijke Bontenbal
, Alistair Ring
, Jerzy Giermek
, Tanja Fehm
, Kristel van Calsteren
, Sabine C. Linn
, Bettina Schlehe
, Mina Mhallem Gziri
, Pieter J. Westenend
, Volkmar Müller
, Liesbeth Heyns
, Brigitte Rack
, Ben van Calster
, Nadia Harbeck
, Miriam Lenhard
, Michael J. Halaska
, Manfred Kaufmann
Valentina Nekljudova, Frederic Amant
Show 2 more
Show less
Other Departments
Affiliatie UvA
Research output
:
Contribution to journal
›
Article
›
Academic
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of breast cancer during pregnancy: an observational study'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Breast Cancer
100%
Observational Study
100%
Premature Labor
42%
Gestational Age
42%
Disease Free Survival
28%
Side Effect
14%
Hazard Ratio
14%
Methotrexate
14%
Congenital Malformation
14%
Low Birth Weight
14%
Birth Weight
14%
First Trimester Pregnancy
14%
Cyclophosphamide
14%
Anthracycline
14%
Fluorouracil
14%
Obstetric Delivery
14%
Maternal Treatment
14%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Observational Study
100%
Premature Labor
42%
Disease Free Survival
28%
Side Effect
14%
Methotrexate
14%
Low Birth Weight
14%
Congenital Malformation
14%
Anthracycline
14%
Cyclophosphamide
14%
Fluorouracil
14%
Taxane
14%
Nursing and Health Professions
Breast Cancer
100%
Premature Labor
42%
Gestational Age
42%
Disease Free Survival
28%
Side Effect
14%
Hazard Ratio
14%
Birth Weight
14%
Congenital Malformation
14%
Anthracycline
14%
Methotrexate
14%
Low Birth Weight
14%
Cyclophosphamide
14%
Fluorouracil
14%
Obstetric Delivery
14%
Maternal Treatment
14%
Immunology and Microbiology
Disease Free Survival
100%
Methotrexate
50%
Low Birth Weight
50%
Cyclophosphamide
50%
First Trimester Pregnancy
50%
Birth Weight
50%
Keyphrases
Full-term Delivery
25%